{"id":"bef63922-9de4-4529-832e-d3d399590510","kind":"companies","code":"UB-C7186","name":"BrainAurora Medical Technology Limited","nameBasis":"source-english","summary":"AI digital therapeutics for cognitive impairment and brain function training software","description":"BrainAurora is a cognitive impairment digital therapeutics group. Listed entity BrainAurora Medical Technology Limited was incorporated in the Cayman Islands in 2023, with its main business location in Beijing, China. Its Chinese operating history began with an operating company in 2012; the two establishment dates refer to different entities.","country":"China","category":null,"originalName":"脑动极光","eventDate":null,"website":"https://www.66nao.cn/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-16T01:13:26.737Z","reviewedAt":"2026-10-16T01:13:26.737Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f44e289f46e93db0c5c1e6d1a981c17be1fe37c8cd78230e2523de89759c6eae","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"AI 认知障碍数字疗法与脑功能训练软件\n\n脑动极光是认知障碍数字疗法集团，上市主体脑动极光医疗科技有限公司于2023年在开曼注册，主要营业地点位于中国北京；中国业务沿革始于2012年的运营公司，二者成立口径不同。","sources":[],"related":[{"id":"651777ad-6893-47df-8cbd-1b8950b497df","kind":"news","code":"651777ad-6893-47df-8cbd-1b8950b497df","name":"BrainAurora completes an IPO","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"脑动极光完成IPO","eventDate":"2025-01-04T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:24.031Z","englishUpdatedAt":"2026-10-15T19:31:54.197Z","reviewedAt":"2026-10-15T19:31:54.197Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d6928fbae13fd8dc894246f1c0761571da86db4c962e1e994c5395be066c378b","companyId":"bef63922-9de4-4529-832e-d3d399590510","foundedYear":null,"logoUrl":null,"path":"/news/651777ad-6893-47df-8cbd-1b8950b497df"},{"id":"960fdd23-6e3b-42e9-8921-732a3ed6acf3","kind":"news","code":"960fdd23-6e3b-42e9-8921-732a3ed6acf3","name":"BrainAurora Medical Technology Limited completes an IPO","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"脑动极光完成IPO","eventDate":"2025-01-08T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-13T17:06:07.725Z","englishUpdatedAt":"2026-10-15T17:19:59.758Z","reviewedAt":"2026-10-15T17:19:59.758Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"b18da3f263c5195347c0044dd2edc050b488dedd58519d5bc53dc0eb4f7baf4f","companyId":"bef63922-9de4-4529-832e-d3d399590510","foundedYear":null,"logoUrl":null,"path":"/news/960fdd23-6e3b-42e9-8921-732a3ed6acf3"},{"id":"daa2f813-305d-4466-9ca8-cf35210f2ca0","kind":"institutions","code":"UB-I1522","name":"元禾原点","nameBasis":"transliterated","summary":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","description":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","country":null,"category":null,"originalName":"元禾原点","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.630Z","englishUpdatedAt":"2026-10-15T21:06:35.433Z","reviewedAt":"2026-10-15T21:06:35.433Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3214074eb40fc79c8d1c92d64ca6a05c08a3a4479b773e5c0ee56f46cd0b1cc1","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yuanheyuandian","path":"/institutions/yuanheyuandian"},{"id":"2398b88d-f544-4b0a-a25f-45466986d90f","kind":"institutions","code":"UB-I6290","name":"天士力医药","nameBasis":"transliterated","summary":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","description":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","country":null,"category":null,"originalName":"天士力医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:21.443Z","englishUpdatedAt":"2026-10-15T18:21:16.967Z","reviewedAt":"2026-10-15T18:21:16.967Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ee5ec0dcea3e791d3cfebf2e0e8363fa60a7b54334e0ab26661e0446dc5de339","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tianshili Pharmaceutical","path":"/institutions/tianshili-pharmaceutical"},{"id":"eb559b27-64e2-40ed-860c-539547f02bfb","kind":"institutions","code":"UB-I6140","name":"黄光伟","nameBasis":"transliterated","summary":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","description":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","country":null,"category":null,"originalName":"黄光伟","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:30:27.050Z","englishUpdatedAt":"2026-10-15T21:21:01.802Z","reviewedAt":"2026-10-15T21:21:01.802Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6c668125ad282735d484d7487e5bf59650dd465c8410c9b261423f9a8ba20417","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huangguangwei","path":"/institutions/huangguangwei"}],"finance":{"funding":{"metric":"funding","count":2,"latest":{"value":83285714,"text":"5.83亿港元","date":"2025-01-08T00:00:00.000Z","round":"IPO","estimate":"HK$583M"},"years":[2025],"points":[{"year":2025,"date":"2025-01-04T00:00:00.000Z","round":"Pre-IPO","value":48500000,"eventIds":["651777ad-6893-47df-8cbd-1b8950b497df"]},{"year":2025,"date":"2025-01-08T00:00:00.000Z","round":"IPO","value":83285714,"eventIds":["960fdd23-6e3b-42e9-8921-732a3ed6acf3"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"960fdd23-6e3b-42e9-8921-732a3ed6acf3","date":"2025-01-08T00:00:00.000Z","round":"IPO","amountText":"5.83亿港元","estimateUsd":83285714,"estimateLabel":"HK$583M","estimateNote":"≈ $83.3M","investors":"未披露","institutions":[],"newsUrl":null,"evidence":{"headline":"BrainAurora Medical Technology Limited completes an IPO","brief":null,"basis":null,"newsPath":"/news/960fdd23-6e3b-42e9-8921-732a3ed6acf3","sourceCount":0}},{"id":"651777ad-6893-47df-8cbd-1b8950b497df","date":"2025-01-04T00:00:00.000Z","round":"Pre-IPO","amountText":"4850万美元","estimateUsd":48500000,"estimateLabel":"$48.5M","estimateNote":null,"investors":"天士力医药,元禾原点,黄光伟","institutions":[{"id":"daa2f813-305d-4466-9ca8-cf35210f2ca0","kind":"institutions","code":"UB-I1522","name":"元禾原点","nameBasis":"transliterated","summary":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","description":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","country":null,"category":null,"originalName":"元禾原点","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.630Z","englishUpdatedAt":"2026-10-15T21:06:35.433Z","reviewedAt":"2026-10-15T21:06:35.433Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3214074eb40fc79c8d1c92d64ca6a05c08a3a4479b773e5c0ee56f46cd0b1cc1","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yuanheyuandian","path":"/institutions/yuanheyuandian"},{"id":"2398b88d-f544-4b0a-a25f-45466986d90f","kind":"institutions","code":"UB-I6290","name":"天士力医药","nameBasis":"transliterated","summary":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","description":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","country":null,"category":null,"originalName":"天士力医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:21.443Z","englishUpdatedAt":"2026-10-15T18:21:16.967Z","reviewedAt":"2026-10-15T18:21:16.967Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ee5ec0dcea3e791d3cfebf2e0e8363fa60a7b54334e0ab26661e0446dc5de339","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tianshili Pharmaceutical","path":"/institutions/tianshili-pharmaceutical"},{"id":"eb559b27-64e2-40ed-860c-539547f02bfb","kind":"institutions","code":"UB-I6140","name":"黄光伟","nameBasis":"transliterated","summary":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","description":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","country":null,"category":null,"originalName":"黄光伟","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:30:27.050Z","englishUpdatedAt":"2026-10-15T21:21:01.802Z","reviewedAt":"2026-10-15T21:21:01.802Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6c668125ad282735d484d7487e5bf59650dd465c8410c9b261423f9a8ba20417","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huangguangwei","path":"/institutions/huangguangwei"}],"newsUrl":null,"evidence":{"headline":"BrainAurora completes an IPO","brief":null,"basis":null,"newsPath":"/news/651777ad-6893-47df-8cbd-1b8950b497df","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":2,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":2,"records":[{"id":"960fdd23-6e3b-42e9-8921-732a3ed6acf3","date":"2025-01-08T00:00:00.000Z","round":"IPO","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"未披露","institutions":[],"newsUrl":null,"evidence":{"headline":"BrainAurora Medical Technology Limited completes an IPO","brief":null,"basis":null,"newsPath":"/news/960fdd23-6e3b-42e9-8921-732a3ed6acf3","sourceCount":0}},{"id":"651777ad-6893-47df-8cbd-1b8950b497df","date":"2025-01-04T00:00:00.000Z","round":"Pre-IPO","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"天士力医药,元禾原点,黄光伟","institutions":[{"id":"daa2f813-305d-4466-9ca8-cf35210f2ca0","kind":"institutions","code":"UB-I1522","name":"元禾原点","nameBasis":"transliterated","summary":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","description":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","country":null,"category":null,"originalName":"元禾原点","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.630Z","englishUpdatedAt":"2026-10-15T21:06:35.433Z","reviewedAt":"2026-10-15T21:06:35.433Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3214074eb40fc79c8d1c92d64ca6a05c08a3a4479b773e5c0ee56f46cd0b1cc1","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yuanheyuandian","path":"/institutions/yuanheyuandian"},{"id":"2398b88d-f544-4b0a-a25f-45466986d90f","kind":"institutions","code":"UB-I6290","name":"天士力医药","nameBasis":"transliterated","summary":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","description":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","country":null,"category":null,"originalName":"天士力医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:21.443Z","englishUpdatedAt":"2026-10-15T18:21:16.967Z","reviewedAt":"2026-10-15T18:21:16.967Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ee5ec0dcea3e791d3cfebf2e0e8363fa60a7b54334e0ab26661e0446dc5de339","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tianshili Pharmaceutical","path":"/institutions/tianshili-pharmaceutical"},{"id":"eb559b27-64e2-40ed-860c-539547f02bfb","kind":"institutions","code":"UB-I6140","name":"黄光伟","nameBasis":"transliterated","summary":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","description":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","country":null,"category":null,"originalName":"黄光伟","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:30:27.050Z","englishUpdatedAt":"2026-10-15T21:21:01.802Z","reviewedAt":"2026-10-15T21:21:01.802Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6c668125ad282735d484d7487e5bf59650dd465c8410c9b261423f9a8ba20417","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huangguangwei","path":"/institutions/huangguangwei"}],"newsUrl":null,"evidence":{"headline":"BrainAurora completes an IPO","brief":null,"basis":null,"newsPath":"/news/651777ad-6893-47df-8cbd-1b8950b497df","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"960fdd23-6e3b-42e9-8921-732a3ed6acf3","kind":"funding","eventDate":"2025-01-08T00:00:00.000Z","revenueDate":null,"round":"IPO","amountText":"5.83亿港元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":83285714,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"未披露","newsUrl":null,"newsTypes":["融资","上市"],"institutions":[],"roundName":"IPO","amountLabel":"HK$583M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null},{"id":"651777ad-6893-47df-8cbd-1b8950b497df","kind":"funding","eventDate":"2025-01-04T00:00:00.000Z","revenueDate":null,"round":"Pre-IPO","amountText":"4850万美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":48500000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"天士力医药,元禾原点,黄光伟","newsUrl":null,"newsTypes":["融资","上市"],"institutions":[{"id":"daa2f813-305d-4466-9ca8-cf35210f2ca0","kind":"institutions","code":"UB-I1522","name":"元禾原点","nameBasis":"transliterated","summary":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","description":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","country":null,"category":null,"originalName":"元禾原点","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.630Z","englishUpdatedAt":"2026-10-15T21:06:35.433Z","reviewedAt":"2026-10-15T21:06:35.433Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3214074eb40fc79c8d1c92d64ca6a05c08a3a4479b773e5c0ee56f46cd0b1cc1","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yuanheyuandian","path":"/institutions/yuanheyuandian"},{"id":"2398b88d-f544-4b0a-a25f-45466986d90f","kind":"institutions","code":"UB-I6290","name":"天士力医药","nameBasis":"transliterated","summary":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","description":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","country":null,"category":null,"originalName":"天士力医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:21.443Z","englishUpdatedAt":"2026-10-15T18:21:16.967Z","reviewedAt":"2026-10-15T18:21:16.967Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ee5ec0dcea3e791d3cfebf2e0e8363fa60a7b54334e0ab26661e0446dc5de339","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tianshili Pharmaceutical","path":"/institutions/tianshili-pharmaceutical"},{"id":"eb559b27-64e2-40ed-860c-539547f02bfb","kind":"institutions","code":"UB-I6140","name":"黄光伟","nameBasis":"transliterated","summary":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","description":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","country":null,"category":null,"originalName":"黄光伟","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:30:27.050Z","englishUpdatedAt":"2026-10-15T21:21:01.802Z","reviewedAt":"2026-10-15T21:21:01.802Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6c668125ad282735d484d7487e5bf59650dd465c8410c9b261423f9a8ba20417","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huangguangwei","path":"/institutions/huangguangwei"}],"roundName":"Pre-IPO","amountLabel":"$48.5M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"daa2f813-305d-4466-9ca8-cf35210f2ca0","kind":"institutions","code":"UB-I1522","name":"元禾原点","nameBasis":"transliterated","summary":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","description":"An early-stage venture capital platform under Yuanhe Holdings, focused on hard technology and medicine.","country":null,"category":null,"originalName":"元禾原点","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.630Z","englishUpdatedAt":"2026-10-15T21:06:35.433Z","reviewedAt":"2026-10-15T21:06:35.433Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3214074eb40fc79c8d1c92d64ca6a05c08a3a4479b773e5c0ee56f46cd0b1cc1","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Yuanheyuandian","path":"/institutions/yuanheyuandian"},{"id":"2398b88d-f544-4b0a-a25f-45466986d90f","kind":"institutions","code":"UB-I6290","name":"天士力医药","nameBasis":"transliterated","summary":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","description":"Tianshili Pharmaceutical is a Chinese strategic investment entity, investing in innovative companies in relevant industries.","country":null,"category":null,"originalName":"天士力医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:32:21.443Z","englishUpdatedAt":"2026-10-15T18:21:16.967Z","reviewedAt":"2026-10-15T18:21:16.967Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ee5ec0dcea3e791d3cfebf2e0e8363fa60a7b54334e0ab26661e0446dc5de339","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Tianshili Pharmaceutical","path":"/institutions/tianshili-pharmaceutical"},{"id":"eb559b27-64e2-40ed-860c-539547f02bfb","kind":"institutions","code":"UB-I6140","name":"黄光伟","nameBasis":"transliterated","summary":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","description":"Huang Guangwei, an individual angel investor supporting seed- to startup-stage projects with personal funds.","country":null,"category":null,"originalName":"黄光伟","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:30:27.050Z","englishUpdatedAt":"2026-10-15T21:21:01.802Z","reviewedAt":"2026-10-15T21:21:01.802Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6c668125ad282735d484d7487e5bf59650dd465c8410c9b261423f9a8ba20417","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Huangguangwei","path":"/institutions/huangguangwei"}],"path":"/companies/UB-C7186","structured":{"city":"Beijing","country":"China","location":null,"role":null,"category":null,"company":null},"definition":"BrainAurora Medical Technology Limited is a company headquartered in Beijing, China.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/UB-C7186"}